Showing results (71-80 of 210) with videos related to
Sort By:
Pageof 21
JBI Evidence Synthesis|February 8, 2024
Monitoring performance of clinical artificial intelligence: a scoping review protocolEline Sandvig Andersen, Johan Baden Birk-Korch, Richard Röttger, et al.Clinical Chemistry and Laboratory Medicine|June 25, 2009
HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissueDorte Aa Olsen, Birthe Ostergaard, Susanne Bokmand, et al.Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
Platelets and anticoagulant capacity in patients with inflammatory bowel diseaseTorben Bjerregaard Larsen, Jens Nederby Nielsen, Lisbeth Fredholm, et al.Cancer Investigation|June 28, 2008
Microsatellite instability and the association with plasma homocysteine and thymidylate synthase in colorectal cancerLars Henrik Jensen, Jan Lindebjerg, Dorthe Gylling Crüger, et al.Ugeskrift for Laeger|April 15, 2008
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations]Aneta Aleksandra Nielsen, Karsten Tange Veien, Lone G M Jørgensen, et al.Clinical Epidemiology|November 2, 2016
Vejle Diabetes Biobank - a resource for studies of the etiologies of diabetes and its comorbiditiesEva Rabing Brix Petersen, Aneta Aleksandra Nielsen, Henry Christensen, et al.Diabetes Research and Clinical Practice|October 27, 2023
Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2DRikke Hjortebjerg, Maja R Kristiansen, Ivan Brandslund, et al.Breast Cancer Research and Treatment|January 25, 2012
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancerElse Maae, Dorte Aalund Olsen, Karina Dahl Steffensen, et al.Anticancer Research|September 21, 2012
Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancerElse Maae, Rikke Fredslund Andersen, Karina Dahl Steffensen, et al.Clinical Chemistry and Laboratory Medicine|December 14, 2007
'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV)Per Hyltoft Petersen, Sverre Sandberg, Natàlia Iglesias, et al.Pageof 21